Arsanis, Inc. (NASDAQ:ASNS) Director Tillman U. Gerngross acquired 200,000 shares of the stock in a transaction that occurred on Monday, November 20th. The stock was purchased at an average cost of $10.00 per share, with a total value of $2,000,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of Arsanis, Inc. (NASDAQ ASNS) opened at $16.16 on Thursday. Arsanis, Inc. has a fifty-two week low of $12.48 and a fifty-two week high of $16.79.

TRADEMARK VIOLATION WARNING: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at

Arsanis Company Profile

Arsanis, Inc is a biopharmaceutical company. The Company is focused on the discovering and developing monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company’s mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500.

Receive News & Ratings for Arsanis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arsanis Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.